Key facts
- This page summarizes Bret Christensen's Form 4 filing for DermTech, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 10 May 2023, 20:02.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Subject to the reporting person's continued service, (i) twelve thirty-sixths (12/36) of the shares of issuer common stock exercisable pursuant to this option shall vest on May 8, 2024 and (ii) the remaining twenty-four thirty-sixths (24/36) shall vest in a series of eight equal quarterly installments on the fifth day of each third month thereafter until the final vesting date on May 5, 2026.